Prognostic Factors of Survival with Aflibercept and FOLFIRI (fluorouracil, leucovorin, irinotecan) as Second-line Therapy for Patients with Metastatic Colorectal Cancer

Background: Aflibercept and fluorouracil, leucovorin, irinotecan (FOLFIRI) is commonly used as a second-line treatment for metastatic colorectal cancer (CRC). However, the biomarkers to guide the choice of this regimen from among treatment options remain unclear. Patients and Methods: We performed e...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jinchul, Kim, Hana, Hong, Jung Yong, Lee, Jeeyun, Park, Se Hoon, Park, Joon Oh, Park, Young Suk, Lim, Ho Yeong, Kang, Won Ki, Kim, Seung Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739009/
https://www.ncbi.nlm.nih.gov/pubmed/33391442
http://dx.doi.org/10.7150/jca.49176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739009/
https://www.ncbi.nlm.nih.gov/pubmed/33391442
http://dx.doi.org/10.7150/jca.49176

Ejemplares similares